A child with dermatomyositis and a suspicious lymphadenopathy

Journal of Rheumatology

Volumn 32, Issue 4, 2005, Pages 744-746

  Martini, Giorgia ^a   Calabrese, Fiorella ^a   Biscaro, Francesca ^a   Zulian, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Juvenile dermatomyositis; Malignancy; Nasopharyngeal carcinoma; Paraneoplastic phenomenon

Indexed keywords

ANTINEOPLASTIC AGENT; GLUCOCORTICOID;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHILDHOOD DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; EPSTEIN BARR VIRUS; FOLLOW UP; HUMAN; LABORATORY TEST; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; TREATMENT INDICATION; UNDIFFERENTIATED CARCINOMA; VIRUS EXAMINATION;

ADOLESCENT; CARCINOMA; COMBINED MODALITY THERAPY; DERMATOMYOSITIS; DISEASE-FREE SURVIVAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPHATIC DISEASES; MALE; NASOPHARYNGEAL NEOPLASMS; PARANEOPLASTIC SYNDROMES; RNA, VIRAL;

EID: 17144377131     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
2. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population based study. N Engl J Med 1992;326:363-7.
3. Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF Jr. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995;5:9-13.
4. Hill C, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100.
5. Yazici Y, Kagen LJ. The association of malignancy with dermatomyositis. Curr Opin Rheumatol 2000;12:498-500.
6. Solomon SD, Maurer KH. Association of dermatomyositis and dysgerminoma in a 16-year-old patient. Arthritis Rheum 1983;26:572-3.
7. Falcini F, Taccetti G, Trapani S, Lippi A, Bartolozzi G. Acute lymphocytic leukemia with dermatomyositis-like onset in childhood [letter]. J Rheumatol 1993;20:1260-1.
8. Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994;21:1855-9.
9. Chan ATC, Teo PML, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002;13:1007-15.
10. Ayan I, Kaytan E, Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol 2003;4:13-21.
11. Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol 1990;28:2398-402.
12. Vasef MA. Nasopharyngeal carcinoma with emphasis on its relationship to EBV. Ann Otol Rhinol Laryngol 1997;106:348-56.
13. Pachman LM, Litt DL, Rowley AH, et al. Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum 1995;38:1513-8.
14. Hu WH, Chen DL, Min HQ. Study of 45 cases of nasopharyngeal carcinoma with dermatomyositis. Am J Clin Oncol 1996;19:35-8.
15. Bernard P, Bonnetblanc JM. Dermatomyositis and malignancy. J Invest Dermatol 1993;100:128S-32S.
16. Amerio P, Girardelli CR, Proietto G, et al. Usefulness of erythrosedimentation rate as tumor marker in cancer associated dermatomyositis. Eur J Dermatol 2002;12:165-9.